Quality of life analysis of TORCH, a randomized trial testing first-line erlotinib followed by second-line cisplatin/gemcitabine chemotherapy in advanced non-small-cell lung cancer. (Q48354672)
Jump to navigation
Jump to search
scientific article published in December 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Quality of life analysis of TORCH, a randomized trial testing first-line erlotinib followed by second-line cisplatin/gemcitabine chemotherapy in advanced non-small-cell lung cancer. |
scientific article published in December 2012 |
Statements
1 reference
Quality of life analysis of TORCH, a randomized trial testing first-line erlotinib followed by second-line cisplatin/gemcitabine chemotherapy in advanced non-small-cell lung cancer. (English)
1 reference
Cesare Gridelli
1 reference
Natasha B Leighl
1 reference
Ciro Gallo
1 reference
Ronald Feld
1 reference
Charles Butts
1 reference
Paolo Maione
1 reference
Rafal Wierzbicki
1 reference
Yasmin Alam
1 reference
Saverio Cinieri
1 reference
Roberto Bianco
1 reference
Ferdinando Riccardi
1 reference
Alberto Ravaioli
1 reference
Raffaella Felletti
1 reference
Vittorio Fregoni
1 reference
Giovenzio Genestreti
1 reference
Gianfranco Mancuso
1 reference
Morena Fasano
1 reference
Simona Signoriello
1 reference
Francesco Perrone
1 reference
TORCH Investigators
1 reference
1 December 2012
1 reference
7
1 reference
12
1 reference
1830-1844
1 reference
Identifiers
1 reference